Combo Products Will Grow More Dependent On Drug Function – Guidant Exec

Product stability, drug release rates and other factors unique to pharmaceuticals will grow increasingly relevant to device firms developing combination products, according to Guidant VP-Endovascular Operations Richard Rapoza, PhD